• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

瘦素在动脉粥样硬化中的作用:聚焦于巨噬细胞、内皮细胞和平滑肌细胞。

Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells.

机构信息

Integrative Medical Sciences, Northeast Ohio Medical University, Rootstown, OH 44272, USA.

School of Biomedical Sciences, Kent State University, Kent, OH 44240, USA.

出版信息

Int J Mol Sci. 2021 May 21;22(11):5446. doi: 10.3390/ijms22115446.

DOI:10.3390/ijms22115446
PMID:34064112
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8196747/
Abstract

Increasing adipose tissue mass in obesity directly correlates with elevated circulating leptin levels. Leptin is an adipokine known to play a role in numerous biological processes including regulation of energy homeostasis, inflammation, vascular function and angiogenesis. While physiological concentrations of leptin may exhibit multiple beneficial effects, chronically elevated pathophysiological levels or hyperleptinemia, characteristic of obesity and diabetes, is a major risk factor for development of atherosclerosis. Hyperleptinemia results in a state of selective leptin resistance such that while beneficial metabolic effects of leptin are dampened, deleterious vascular effects of leptin are conserved attributing to vascular dysfunction. Leptin exerts potent proatherogenic effects on multiple vascular cell types including macrophages, endothelial cells and smooth muscle cells; these effects are mediated via an interaction of leptin with the long form of leptin receptor, abundantly expressed in atherosclerotic plaques. This review provides a summary of recent in vivo and in vitro studies that highlight a role of leptin in the pathogenesis of atherosclerotic complications associated with obesity and diabetes.

摘要

肥胖症中脂肪组织质量的增加与循环中瘦素水平的升高直接相关。瘦素是一种脂肪细胞因子,已知在许多生物学过程中发挥作用,包括能量稳态调节、炎症、血管功能和血管生成。虽然瘦素的生理浓度可能表现出多种有益的作用,但肥胖症和糖尿病特征性的慢性升高的病理生理水平或高瘦素血症是动脉粥样硬化发展的主要危险因素。高瘦素血症导致选择性瘦素抵抗,从而削弱了瘦素的有益代谢作用,而保留了瘦素的有害血管作用,导致血管功能障碍。瘦素对包括巨噬细胞、内皮细胞和平滑肌细胞在内的多种血管细胞类型产生强烈的促动脉粥样硬化作用;这些作用是通过瘦素与在动脉粥样硬化斑块中大量表达的瘦素受体的长形式相互作用介导的。本综述提供了最近的体内和体外研究的总结,这些研究强调了瘦素在与肥胖和糖尿病相关的动脉粥样硬化并发症发病机制中的作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/49042f334fa7/ijms-22-05446-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/8c0e530e055a/ijms-22-05446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/c0d97a784888/ijms-22-05446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/a9175cbc2557/ijms-22-05446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/31bf05391174/ijms-22-05446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/49042f334fa7/ijms-22-05446-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/8c0e530e055a/ijms-22-05446-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/c0d97a784888/ijms-22-05446-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/a9175cbc2557/ijms-22-05446-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/31bf05391174/ijms-22-05446-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/7d81/8196747/49042f334fa7/ijms-22-05446-g005.jpg

相似文献

1
Leptin in Atherosclerosis: Focus on Macrophages, Endothelial and Smooth Muscle Cells.瘦素在动脉粥样硬化中的作用:聚焦于巨噬细胞、内皮细胞和平滑肌细胞。
Int J Mol Sci. 2021 May 21;22(11):5446. doi: 10.3390/ijms22115446.
2
Selective Deletion of Leptin Signaling in Endothelial Cells Enhances Neointima Formation and Phenocopies the Vascular Effects of Diet-Induced Obesity in Mice.内皮细胞中瘦素信号的选择性缺失增强了小鼠的新生内膜形成,并模拟了饮食诱导肥胖的血管效应。
Arterioscler Thromb Vasc Biol. 2017 Sep;37(9):1683-1697. doi: 10.1161/ATVBAHA.117.309798. Epub 2017 Jul 13.
3
Necroptosis in atherosclerosis.动脉粥样硬化中的细胞坏死性凋亡。
Clin Chim Acta. 2022 Sep 1;534:22-28. doi: 10.1016/j.cca.2022.07.004. Epub 2022 Jul 7.
4
PCSK9 and atherosclerosis: Looking beyond LDL regulation.PCSK9 与动脉粥样硬化:超越 LDL 调控的视角。
Eur J Clin Invest. 2021 Apr;51(4):e13459. doi: 10.1111/eci.13459. Epub 2020 Dec 3.
5
MicroRNA-126, -145, and -155: a therapeutic triad in atherosclerosis?微小 RNA-126、-145 和 -155:动脉粥样硬化治疗三联体?
Arterioscler Thromb Vasc Biol. 2013 Mar;33(3):449-54. doi: 10.1161/ATVBAHA.112.300279. Epub 2013 Jan 16.
6
Hypoxia inducible factor as a therapeutic target for atherosclerosis.缺氧诱导因子作为动脉粥样硬化的治疗靶点。
Pharmacol Ther. 2018 Mar;183:22-33. doi: 10.1016/j.pharmthera.2017.09.003. Epub 2017 Sep 20.
7
Immunostaining of Macrophages, Endothelial Cells, and Smooth Muscle Cells in the Atherosclerotic Mouse Aorta.动脉粥样硬化小鼠主动脉中巨噬细胞、内皮细胞和平滑肌细胞的免疫染色
Methods Mol Biol. 2015;1339:131-48. doi: 10.1007/978-1-4939-2929-0_9.
8
Upregulation of thrombospondin-1 expression by leptin in vascular smooth muscle cells via JAK2- and MAPK-dependent pathways.瘦素通过 JAK2 和 MAPK 依赖性途径上调血管平滑肌细胞中血栓素-1 的表达。
Am J Physiol Cell Physiol. 2012 Jul 15;303(2):C179-91. doi: 10.1152/ajpcell.00008.2012. Epub 2012 May 16.
9
Endothelial Cell-Specific Deletion of P2Y2 Receptor Promotes Plaque Stability in Atherosclerosis-Susceptible ApoE-Null Mice.内皮细胞特异性缺失P2Y2受体可促进动脉粥样硬化易感载脂蛋白E基因敲除小鼠的斑块稳定性。
Arterioscler Thromb Vasc Biol. 2017 Jan;37(1):75-83. doi: 10.1161/ATVBAHA.116.308561. Epub 2016 Nov 17.
10
Leptin and atherosclerosis.瘦素与动脉粥样硬化。
Atherosclerosis. 2006 Nov;189(1):47-60. doi: 10.1016/j.atherosclerosis.2006.03.003. Epub 2006 Apr 3.

引用本文的文献

1
Cellular and Molecular Mechanisms of VSMC Phenotypic Switching in Type 2 Diabetes.2型糖尿病中血管平滑肌细胞表型转换的细胞和分子机制
Cells. 2025 Sep 2;14(17):1365. doi: 10.3390/cells14171365.
2
Exercise in atherosclerosis: its beneficial effects and underlying mechanism.动脉粥样硬化中的运动:其有益作用及潜在机制。
Front Cell Dev Biol. 2025 Aug 11;13:1598794. doi: 10.3389/fcell.2025.1598794. eCollection 2025.
3
Mechanisms through which laparoscopic sleeve gastrectomy mitigates atherosclerosis risk: a focus on visceral adipose tissue.

本文引用的文献

1
Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association.心脏病与中风统计-2021 更新:美国心脏协会报告。
Circulation. 2021 Feb 23;143(8):e254-e743. doi: 10.1161/CIR.0000000000000950. Epub 2021 Jan 27.
2
TSP-1 (Thrombospondin-1) Deficiency Protects ApoE Mice Against Leptin-Induced Atherosclerosis.TSP-1(血小板反应蛋白-1)缺乏可保护载脂蛋白 E 小鼠免受瘦素诱导的动脉粥样硬化。
Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):e112-e127. doi: 10.1161/ATVBAHA.120.314962. Epub 2020 Dec 17.
3
Vascular Cells Proteome Associated with Bradykinin and Leptin Inflammation and Oxidative Stress Signals.
腹腔镜袖状胃切除术降低动脉粥样硬化风险的机制:关注内脏脂肪组织
Eur J Med Res. 2025 May 7;30(1):370. doi: 10.1186/s40001-025-02635-y.
4
Targeting Epicardial/Pericardial Adipose Tissue in Cardiovascular Diseases: A Novel Therapeutic Strategy.靶向心血管疾病中的心外膜/心包脂肪组织:一种新型治疗策略。
Rev Cardiovasc Med. 2025 Mar 13;26(3):26128. doi: 10.31083/RCM26128. eCollection 2025 Mar.
5
Management of cardiovascular disease by cerium oxide nanoparticles via alleviating oxidative stress and adipokine abnormalities.通过减轻氧化应激和脂肪因子异常,利用氧化铈纳米颗粒管理心血管疾病。
Sci Rep. 2025 Feb 17;15(1):5709. doi: 10.1038/s41598-025-85794-6.
6
Lipid Metabolism: An Emerging Player in Sjögren's Syndrome.脂质代谢:干燥综合征中一个新出现的因素
Clin Rev Allergy Immunol. 2025 Feb 11;68(1):15. doi: 10.1007/s12016-025-09023-8.
7
Leptin Resistance and Cardiometabolic Disorders: Bridging Molecular Pathways, Genetic Variants, and Therapeutic Innovation.瘦素抵抗与心脏代谢紊乱:连接分子途径、基因变异与治疗创新
Curr Cardiol Rev. 2025;21(5):52-67. doi: 10.2174/011573403X356019250118170444.
8
Treating Metabolic Dysregulation and Senescence by Caloric Restriction: Killing Two Birds with One Stone?通过热量限制治疗代谢失调和衰老:一石二鸟?
Antioxidants (Basel). 2025 Jan 16;14(1):99. doi: 10.3390/antiox14010099.
9
High-Fat Diet, Epigenetics, and Atherosclerosis: A Narrative Review.高脂饮食、表观遗传学与动脉粥样硬化:一篇综述
Nutrients. 2024 Dec 31;17(1):127. doi: 10.3390/nu17010127.
10
Exosomal NEDD4L derived from HG+oxLDL-induced vascular endothelial cells accelerates macrophage M1 polarization and oxLDL uptake by ubiquitinating IκBα and PPARγ.源自高糖+氧化低密度脂蛋白诱导的血管内皮细胞的外泌体NEDD4L通过泛素化IκBα和PPARγ加速巨噬细胞M1极化和氧化低密度脂蛋白摄取。
Cell Biol Toxicol. 2025 Jan 7;41(1):23. doi: 10.1007/s10565-024-09973-3.
与缓激肽和瘦素炎症及氧化应激信号相关的血管细胞蛋白质组
Antioxidants (Basel). 2020 Dec 9;9(12):1251. doi: 10.3390/antiox9121251.
4
Association between plasma leptin/adiponectin ratios with the extent and severity of coronary artery disease.血浆瘦素/脂联素比值与冠状动脉疾病程度和严重程度的关系。
BMC Cardiovasc Disord. 2020 Nov 4;20(1):474. doi: 10.1186/s12872-020-01723-7.
5
Extracellular matrix dynamics in vascular remodeling.血管重构中的细胞外基质动力学。
Am J Physiol Cell Physiol. 2020 Sep 1;319(3):C481-C499. doi: 10.1152/ajpcell.00147.2020. Epub 2020 Jun 24.
6
Matrix Metalloproteinases as Biomarkers of Atherosclerotic Plaque Instability.基质金属蛋白酶作为动脉粥样硬化斑块不稳定的生物标志物。
Int J Mol Sci. 2020 May 31;21(11):3946. doi: 10.3390/ijms21113946.
7
Role of thrombospondin‑1 and thrombospondin‑2 in cardiovascular diseases (Review).血栓反应蛋白-1 和血栓反应蛋白-2 在心血管疾病中的作用(综述)。
Int J Mol Med. 2020 May;45(5):1275-1293. doi: 10.3892/ijmm.2020.4507. Epub 2020 Feb 20.
8
The Role of Secretory Activity Molecules of Visceral Adipocytes in Abdominal Obesity in the Development of Cardiovascular Disease: A Review.内脏脂肪细胞分泌活性分子在腹型肥胖及其相关心血管疾病发生发展中的作用:综述
Biomolecules. 2020 Feb 28;10(3):374. doi: 10.3390/biom10030374.
9
Endothelial Dysfunction in Obesity-Induced Inflammation: Molecular Mechanisms and Clinical Implications.肥胖引起的炎症中的血管内皮功能障碍:分子机制和临床意义。
Biomolecules. 2020 Feb 13;10(2):291. doi: 10.3390/biom10020291.
10
The association between leptin concentration and blood coagulation: Results from the NEO study.瘦素浓度与凝血的关系:来自 NEO 研究的结果。
Thromb Res. 2020 Apr;188:44-48. doi: 10.1016/j.thromres.2020.01.021. Epub 2020 Jan 21.